This course reviews the hematological system and provides an overview on the spectrum of hematological cancers.
The pathophysiology of hematological malignancies such as leukemias, lymphomas and myeloma are discussed along with their common treatments. The issues and complications of bone marrow and stem cell transplant will be reviewed. Matters relating to clinical trial issues including ethical considerations and FDA directives will be examined.
Case studies and open discussion will form an integral part of the program.
Who should attend?
Healthcare’s courses are designed for both medical and non-medical staff within the pharmaceutical industry. This course is suitable for clinical research, medical information, regulatory affairs, biometrics and strategic marketing personnel.
Topics to be covered include:
The formation and maturation of blood cells
Classification and epidemiology of hematological malignancies
Presentation, diagnosis and staging
Chemotherapy and irradiation
Clinical trial issues
Dennis L Cooper MD, Professor of Medicine (Hematology), Yale Cancer Center, New Haven, USA
Carol Ann Huff MD, Associate Professor of Medicine and Oncology, Sidney Kimmel Comprehensive Cancer Center, Baltimore
Mark Levis MD, Associate Professor of Oncology, Pharmacology, and Medicine, Sidney Kimmel Comprehensive Cancer Center, Baltimore
Douglas Smith MD, Associate Professor, Hematologic Malignancies, Sidney Kimmel Comprehensive Cancer Center, Baltimore